Repligen Corp (RGEN) Tops Q2 EPS by 4c

October 27, 2011 5:27 PM

Repligen Corp (NASDAQ: RGEN) reported Q2 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $8.63 million versus the consensus estimate of $7.5 million.

No results found